These 10 ASX growth shares delivered returns between 9% and 306% in just three months. Get the market caps, P/E ratios, and key catalysts driving each stock's performance, plus learn how to trade them through IG AU.
Written by
Financial writer
Reviewed by
Financial UX Writer
This article is for informational purposes only and does not constitute investment or trading advice. Please ensure you understand the risks and consider your individual circumstances before trading.
ASX growth shares are companies that reinvest profits to fuel rapid expansion rather than pay dividends. The 10 stocks in this article prove the point - they've delivered returns between 9% and 306% in just three months.
These companies typically trade at high price-to-earning (P/E) ratios because investors pay a premium for future growth. For example, NEXTDC trades at a P/E of 500, while Pro Medicus sits at 349 - both reflecting expectations of continued expansion.
The top ASX growth shares often dominate niche markets through proprietary technology. This is true in the case of Cochlear's hearing implants, WiseTech's logistics software used in 130+ countries, or DroneShield's AI-powered drone detection systems.
The trade-off? Growth stocks can fall as fast as they rise. Miss quarterly expectations by even a small margin, and share prices can tumble rapidly.
The stocks featured in this article exemplify the volatility inherent in growth shares. Take DroneShield, for instance, which experienced a remarkable 306% surge in just three months. In contrast, even reliable performers like CSL achieved a more modest 9% gain, highlighting the diverse range of outcomes within this investment category.
Growth shares occupy a middle ground between high-risk penny stocks and the more stable blue-chip dividend stocks. They offer the potential for substantial gains without the extreme volatility of speculative plays.
However, the risk lies in the fact that these companies typically reinvest profits rather than distribute dividends, meaning investors rely solely on share price appreciation. Failure to meet growth targets can result in share prices falling as dramatically as they rise.
Savvy traders diversify their portfolios across multiple growth stocks and sectors. Our selection includes tech companies like Xero and WiseTech, healthcare leaders such as Cochlear and CSL, mining giants like Mineral Resources, and defense firms like DroneShield, thereby spreading risk across various growth drivers.
The reward potential is clear: even our "slowest" performer delivered 9% in three months, while the top performers delivered substantial returns.
Several powerful catalysts are driving exceptional ASX growth share performance in 2025, with our featured stocks gaining 9%-306% in just three months.
Australia's stable regulatory environment and strong mining/tech sectors provide a perfect launchpad for these growth stories to unfold.
From DroneShield's 306% surge to CSL's steady 9% climb, these 10 stocks delivered exceptional returns between April and July 2025. Here's what each company offers and why traders are paying attention.
Our selection criteria
Past performance doesn't guarantee future returns - all investments and trades carry risk.
You can trade all of the shares listed in this article via CFDs through our platform, and also directly buy and sell all of them via our share trading platform.
Company |
Market cap |
P/E ratio |
Highlight |
Trade the share CFD with us? |
Share trade the stock with us? |
A$9.12 billion |
500 |
Australia's leading Tier‑III and IV data centre operator |
✓ |
✓ |
|
A$34.26 billion |
349.17 |
A$20 million five-year deal with the University of Iowa |
✓ |
✓ |
|
A$38.31 billion |
124.40 |
Flagship CargoWise platform used in 130+ countries |
✓ |
✓ |
|
A$29.79 billion |
133.68 |
Operates in Australia, New Zealand, the UK, South Africa, Canada, the US and Singapore |
✓ |
✓ |
|
A$124.63 billion |
30.05 |
Plasma therapies, vaccines, and gene and cell therapy innovations |
✓ |
✓ |
|
A$83.11 billion |
23.31 |
Australia’s largest investment bank and asset manager |
✓ |
✓ |
|
A$71.03 billion |
73.92 |
Global leader in developing industrial real estate and hyperscale data centres |
✓ |
✓ |
|
A$20.29 billion |
54.99 |
Leading global hearing implant company |
✓ |
✓ |
|
A$3 billion |
43.28 |
AI‑powered hardware and software to detect, track and neutralise drone threats |
✓ |
✓ |
|
A$5.67 billion |
32.64 |
Operates in lithium and iron ore across Western Australia |
✓ |
✓ |
Market cap: A$9.12 billion1
P/E ratio: 5002
As Australia's leading Tier‑III and IV data centre operator, NEXTDC services global hyperscalers, cloud providers and AI-native enterprises.
The company is heavily investing in sustainability initiatives by building an energy-efficient platform, and it offers its customers the option to offset the carbon footprint of their digital infrastructure through its NEXTneutral initiative.
Highlights:
Industry: medical
Market cap: A$34.26 billion5
P/E ratio: 349.176
Pro Medicus provides medical imaging software, servicing hospitals, imaging centres and healthcare groups globally.
The company recently (May 2025) announced a lucrative A$20 million five-year deal with the University of Iowa to roll out its Visage product across campuses, opening up a massive US market for the Australian business.
Highlights:
Industry: logistics software/software-as-a-service (SaaS)
Market cap: A$38.31 billion9
P/E ratio: 124.4010
WiseTech is most well-known for its CargoWise platform, used by major freight forwarders, customs authorities and shippers in over 130 countries. These include territories in Asia, the Americas and Europe.
It recently acquired e2open, an NYSE-listed company in SaaS solutions for the global logistics industry. This extends WiseTech’s offering in domestic logistics, carrier integration, and global trade and supply chain management.
Highlights:
Industry: fintech/SaaS
Market cap: A$29.79 billion13
P/E ratio: 133.6814
As an accounting software of choice for small-to-medium businesses in Australia, New Zealand and the UK, Xero helps the little guy manage finances and operations. Its cloud-based platform automates various accounting procedures, such as invoicing, bank reconciliation and more.
It also operates in South Africa, Singapore, Canada and the US.
It’s seen a decent escalation in its share price, having been at A$142.26 on 7 April 2025 and at A$179.76 on 21 July 2025. In between, it reached a high of A$194.21.
Highlights:
Industry: biopharmaceuticals
Market cap: A$124.63 billion17
P/E ratio: 30.0518
CSL is known for its plasma therapies, vaccines, and gene and cell therapy innovations. It continues to invest heavily in R&D, which uses a substantial portion of its profits to drive future growth.
Its research includes plasma protein and recombinant tech and therapeutics (eg haematology and immunology).
The company is split into different sections: CSL Behring, CSL Seqirus and CSL Vifor, which treat rare diseases, develop vaccines, and deal with iron deficiency and nephrological diseases, respectively.
Its most recent half-year results show strong growth for all divisions of the business.
Highlights:
Industry: finance
Market cap: A$83.11 billion20
P/E ratio: 23.3121
Macquarie is Australia’s largest investment bank and asset manager, and has diversified exposure to global markets, such as green energy, commodities and more. It has A$941 billion in assets under management.22
Its current primary focus is on investing in clean energy and upgrading its digital infrastructure.
It reported an FY25 net profit of A$3.715 million, up 5% on FY24 in its latest earnings release, indicating solid growth for the company.23
Highlights:
Industry: industrial property/data centres
Market cap: A$71.03 billion26
P/E ratio: 73.9227
Goodman Group is a global leader in developing industrial real estate and hyperscale data centres. It has a solid development pipeline across Europe, North America, Japan and China.
Its diversification between real estate and data centres points to short- and long-term earnings growth, with recurring rent income and its key AI infrastructure enablers.
Highlights:
Industry: medical
Market cap: A$20.29 billion30
P/E ratio: 54.9931
Through international expansion, Cochlear has shown strong growth in performance. As the leading global hearing implant company, it expects implant sales to grow by 10% this year still.32
The company also expects to help over 50,000 people for FY25 with their cochlear or acoustic implant products.
Due to the nature of the industry, there’s a high barrier to entry for smaller companies, so Cochlear is likely to continue its positive performance for the foreseeable future.
Highlights:
Industry: defence technology
Market cap: A$3 billion35
P/E ratio: 43.2836
DroneShield specialises in AI-powered hardware and software solutions designed to detect, track, and neutralise drone threats. Their technology serves crucial sectors such as national defense, law enforcement, and critical infrastructure, providing robust protection against potential drone-related risks.
It has clients in Ukraine, the US, Europe, Asia and Latin America.
DroneShield maintains a very low debt profile, enabling the company to channel profits into long-term strategic investments without heavy financial obligations.
The ongoing geopolitical instability in the Middle East and Eastern Europe continues to drive heightened demand for defence technology globally.
Highlights:
Industry: mining
Market cap: A$5.67 billion39
P/E ratio: 32.6440
Mineral Resources is a diversified mining company, operating in lithium and iron ore across Western Australia. Its wholly owned subsidiary, CSI Mining Services, provides sustainable services supporting Mineral Resources projects and Tier 1 mining clients.
The company is also committed to improving sustainability in its business by lowering emissions and pursuing opportunities for natural gas to power its operations.
Its consistently solid returns and growth investment make this last share on our list one to watch.
Highlights:
1. Open a CFD trading account with IG AU
2. Search for ASX growth shares on the IG platform
3. Decide whether to go long (buy) or short (sell)
4. Choose your position size
5. Set stop-loss and limit orders
6. Place your trade and monitor it
1. Open a share trading account with IG AU
2. Search for ASX growth shares available for direct ownership
3. Choose the stock you want to buy
4. Determine how many shares you want to purchase
5. Place your order
6. Monitor your investment
The top performing ASX growth shares in 2025 include DroneShield (306% gain), Mineral Resources (108% gain), WiseTech Global (57% gain), and NEXTDC (42% gain) over a three-month period from April to July 2025. Other strong performers include Goodman Group (33% gain) and Macquarie (30% gain).
You can trade ASX growth shares through CFD trading or direct share ownership via IG AU. You'll need to open either a CFD trading account or share trading account with IG AU.
Most ASX growth shares, including the companies in this list, typically don't pay dividends or pay minimal dividends. Instead, they reinvest profits into research and development, infrastructure expansion, and business growth to drive future share price appreciation.
ASX growth shares typically trade at high P/E ratios reflecting future growth expectations. Examples include NEXTDC (500), Pro Medicus (349.17), Xero (133.68), and WiseTech Global (124.40). More established companies like CSL (30.05) and Macquarie (23.31) trade at lower ratios.
The featured ASX growth shares span diverse sectors including technology (NEXTDC, WiseTech), healthcare (CSL, Cochlear, Pro Medicus), fintech (Xero), mining (Mineral Resources), defence (DroneShield), finance (Macquarie), and industrial property/data centres (Goodman Group).
ASX growth shares are known for their volatility, presenting a higher risk but also the potential for significant rewards. For instance, DroneShield achieved a remarkable 306% gain, while CSL saw a more modest 9% increase over the same period. Beginners should understand the high-risk, high-reward nature and consider diversifying across multiple growth shares and sectors.
This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Ready to open an IG account?
Start your trading journey now
New clients
+65 6390 5133
accountopening@ig.com.sg
Existing clients
+65 6390 5118
helpdesk@ig.com.sg
Lines open 24 hours
Monday - Friday
Start a Whatsapp chat
Disclaimers: